[1]
Norman, A.H. et al. 2017. Linking high-risk preventive strategy to biomedical-industry market: implications for public health. Saúde e Sociedade. 26, 3 (Sep. 2017), 638–650. DOI:https://doi.org/10.1590/s0104-12902017172682.